Stratified analyses showed no differences in the risk of SIS when prescribed GLP-1RA or SGLT-2i between participants with and without depression, anxiety or sleep disorders, between women and men, and between individuals in different obesity categories (ESM Fig
Feel a deep skin renewal with GHK-Cu Copper Peptide Face Cream
Compounding pharmacies were required to stop production by April 22, 2025
While effective, GLP-1 receptor agonists can have several side effects
Most headaches are mild and respond to standard headache management approaches, but persistent or severe headaches should be evaluated
1 Statements "In Canada, over one in four adults aged 18 and older grapple with the complexities of obesity, a pressing health concern